We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Declines to Approve Cempra’s CABP Antibiotic Solithera
FDA Declines to Approve Cempra’s CABP Antibiotic Solithera
The FDA refused to approve Cempra’s community-acquired bacterial pneumonia antibiotic Solithera, citing manufacturing and safety concerns in a complete response letter.